Global Multivalent Influenza Vaccines Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Multivalent Influenza Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Multivalent Influenza Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Multivalent Influenza Vaccines market in any manner.
Global Multivalent Influenza Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
Bcht Biotechnology
Jiangsu GDK
KM Biologics
ADIMMUNE Corporation
Aleph Biomedical
Shanghai Institute of Biological Products
Zhongyianke Biotech
Wuhan Institute of Biological Products
Market Segmentation (by Type)
Trivalent Inactivated Influenza Vaccine (IIV3)
Trivalent Live Attenuated Vaccine (LAIV3)
Quadrivalent Inactivated Influenza Vaccine (IIV4)
Market Segmentation (by Application)
6 Months to 3 Years
Above 3 Years
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Multivalent Influenza Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Multivalent Influenza Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Multivalent Influenza Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Multivalent Influenza Vaccines market in any manner.
Global Multivalent Influenza Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
Bcht Biotechnology
Jiangsu GDK
KM Biologics
ADIMMUNE Corporation
Aleph Biomedical
Shanghai Institute of Biological Products
Zhongyianke Biotech
Wuhan Institute of Biological Products
Market Segmentation (by Type)
Trivalent Inactivated Influenza Vaccine (IIV3)
Trivalent Live Attenuated Vaccine (LAIV3)
Quadrivalent Inactivated Influenza Vaccine (IIV4)
Market Segmentation (by Application)
6 Months to 3 Years
Above 3 Years
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Multivalent Influenza Vaccines Market
- Overview of the regional outlook of the Multivalent Influenza Vaccines Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Multivalent Influenza Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Multivalent Influenza Vaccines
1.2 Key Market Segments
1.2.1 Multivalent Influenza Vaccines Segment by Type
1.2.2 Multivalent Influenza Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MULTIVALENT INFLUENZA VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Multivalent Influenza Vaccines Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Multivalent Influenza Vaccines Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MULTIVALENT INFLUENZA VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Global Multivalent Influenza Vaccines Sales by Manufacturers (2019-2024)
3.2 Global Multivalent Influenza Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.3 Multivalent Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Multivalent Influenza Vaccines Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Multivalent Influenza Vaccines Sales Sites, Area Served, Product Type
3.6 Multivalent Influenza Vaccines Market Competitive Situation and Trends
3.6.1 Multivalent Influenza Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Multivalent Influenza Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MULTIVALENT INFLUENZA VACCINES INDUSTRY CHAIN ANALYSIS
4.1 Multivalent Influenza Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MULTIVALENT INFLUENZA VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MULTIVALENT INFLUENZA VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Multivalent Influenza Vaccines Sales Market Share by Type (2019-2024)
6.3 Global Multivalent Influenza Vaccines Market Size Market Share by Type (2019-2024)
6.4 Global Multivalent Influenza Vaccines Price by Type (2019-2024)
7 MULTIVALENT INFLUENZA VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Multivalent Influenza Vaccines Market Sales by Application (2019-2024)
7.3 Global Multivalent Influenza Vaccines Market Size (M USD) by Application (2019-2024)
7.4 Global Multivalent Influenza Vaccines Sales Growth Rate by Application (2019-2024)
8 MULTIVALENT INFLUENZA VACCINES MARKET SEGMENTATION BY REGION
8.1 Global Multivalent Influenza Vaccines Sales by Region
8.1.1 Global Multivalent Influenza Vaccines Sales by Region
8.1.2 Global Multivalent Influenza Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Multivalent Influenza Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Multivalent Influenza Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Multivalent Influenza Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Multivalent Influenza Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Multivalent Influenza Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Sanofi
9.1.1 Sanofi Multivalent Influenza Vaccines Basic Information
9.1.2 Sanofi Multivalent Influenza Vaccines Product Overview
9.1.3 Sanofi Multivalent Influenza Vaccines Product Market Performance
9.1.4 Sanofi Business Overview
9.1.5 Sanofi Multivalent Influenza Vaccines SWOT Analysis
9.1.6 Sanofi Recent Developments
9.2 CSL
9.2.1 CSL Multivalent Influenza Vaccines Basic Information
9.2.2 CSL Multivalent Influenza Vaccines Product Overview
9.2.3 CSL Multivalent Influenza Vaccines Product Market Performance
9.2.4 CSL Business Overview
9.2.5 CSL Multivalent Influenza Vaccines SWOT Analysis
9.2.6 CSL Recent Developments
9.3 GSK
9.3.1 GSK Multivalent Influenza Vaccines Basic Information
9.3.2 GSK Multivalent Influenza Vaccines Product Overview
9.3.3 GSK Multivalent Influenza Vaccines Product Market Performance
9.3.4 GSK Multivalent Influenza Vaccines SWOT Analysis
9.3.5 GSK Business Overview
9.3.6 GSK Recent Developments
9.4 Viatris
9.4.1 Viatris Multivalent Influenza Vaccines Basic Information
9.4.2 Viatris Multivalent Influenza Vaccines Product Overview
9.4.3 Viatris Multivalent Influenza Vaccines Product Market Performance
9.4.4 Viatris Business Overview
9.4.5 Viatris Recent Developments
9.5 AstraZeneca
9.5.1 AstraZeneca Multivalent Influenza Vaccines Basic Information
9.5.2 AstraZeneca Multivalent Influenza Vaccines Product Overview
9.5.3 AstraZeneca Multivalent Influenza Vaccines Product Market Performance
9.5.4 AstraZeneca Business Overview
9.5.5 AstraZeneca Recent Developments
9.6 Hualan Bio
9.6.1 Hualan Bio Multivalent Influenza Vaccines Basic Information
9.6.2 Hualan Bio Multivalent Influenza Vaccines Product Overview
9.6.3 Hualan Bio Multivalent Influenza Vaccines Product Market Performance
9.6.4 Hualan Bio Business Overview
9.6.5 Hualan Bio Recent Developments
9.7 Changchun Institute of Biological
9.7.1 Changchun Institute of Biological Multivalent Influenza Vaccines Basic Information
9.7.2 Changchun Institute of Biological Multivalent Influenza Vaccines Product Overview
9.7.3 Changchun Institute of Biological Multivalent Influenza Vaccines Product Market Performance
9.7.4 Changchun Institute of Biological Business Overview
9.7.5 Changchun Institute of Biological Recent Developments
9.8 Sinovac
9.8.1 Sinovac Multivalent Influenza Vaccines Basic Information
9.8.2 Sinovac Multivalent Influenza Vaccines Product Overview
9.8.3 Sinovac Multivalent Influenza Vaccines Product Market Performance
9.8.4 Sinovac Business Overview
9.8.5 Sinovac Recent Developments
9.9 Bcht Biotechnology
9.9.1 Bcht Biotechnology Multivalent Influenza Vaccines Basic Information
9.9.2 Bcht Biotechnology Multivalent Influenza Vaccines Product Overview
9.9.3 Bcht Biotechnology Multivalent Influenza Vaccines Product Market Performance
9.9.4 Bcht Biotechnology Business Overview
9.9.5 Bcht Biotechnology Recent Developments
9.10 Jiangsu GDK
9.10.1 Jiangsu GDK Multivalent Influenza Vaccines Basic Information
9.10.2 Jiangsu GDK Multivalent Influenza Vaccines Product Overview
9.10.3 Jiangsu GDK Multivalent Influenza Vaccines Product Market Performance
9.10.4 Jiangsu GDK Business Overview
9.10.5 Jiangsu GDK Recent Developments
9.11 KM Biologics
9.11.1 KM Biologics Multivalent Influenza Vaccines Basic Information
9.11.2 KM Biologics Multivalent Influenza Vaccines Product Overview
9.11.3 KM Biologics Multivalent Influenza Vaccines Product Market Performance
9.11.4 KM Biologics Business Overview
9.11.5 KM Biologics Recent Developments
9.12 ADIMMUNE Corporation
9.12.1 ADIMMUNE Corporation Multivalent Influenza Vaccines Basic Information
9.12.2 ADIMMUNE Corporation Multivalent Influenza Vaccines Product Overview
9.12.3 ADIMMUNE Corporation Multivalent Influenza Vaccines Product Market Performance
9.12.4 ADIMMUNE Corporation Business Overview
9.12.5 ADIMMUNE Corporation Recent Developments
9.13 Aleph Biomedical
9.13.1 Aleph Biomedical Multivalent Influenza Vaccines Basic Information
9.13.2 Aleph Biomedical Multivalent Influenza Vaccines Product Overview
9.13.3 Aleph Biomedical Multivalent Influenza Vaccines Product Market Performance
9.13.4 Aleph Biomedical Business Overview
9.13.5 Aleph Biomedical Recent Developments
9.14 Shanghai Institute of Biological Products
9.14.1 Shanghai Institute of Biological Products Multivalent Influenza Vaccines Basic Information
9.14.2 Shanghai Institute of Biological Products Multivalent Influenza Vaccines Product Overview
9.14.3 Shanghai Institute of Biological Products Multivalent Influenza Vaccines Product Market Performance
9.14.4 Shanghai Institute of Biological Products Business Overview
9.14.5 Shanghai Institute of Biological Products Recent Developments
9.15 Zhongyianke Biotech
9.15.1 Zhongyianke Biotech Multivalent Influenza Vaccines Basic Information
9.15.2 Zhongyianke Biotech Multivalent Influenza Vaccines Product Overview
9.15.3 Zhongyianke Biotech Multivalent Influenza Vaccines Product Market Performance
9.15.4 Zhongyianke Biotech Business Overview
9.15.5 Zhongyianke Biotech Recent Developments
9.16 Wuhan Institute of Biological Products
9.16.1 Wuhan Institute of Biological Products Multivalent Influenza Vaccines Basic Information
9.16.2 Wuhan Institute of Biological Products Multivalent Influenza Vaccines Product Overview
9.16.3 Wuhan Institute of Biological Products Multivalent Influenza Vaccines Product Market Performance
9.16.4 Wuhan Institute of Biological Products Business Overview
9.16.5 Wuhan Institute of Biological Products Recent Developments
10 MULTIVALENT INFLUENZA VACCINES MARKET FORECAST BY REGION
10.1 Global Multivalent Influenza Vaccines Market Size Forecast
10.2 Global Multivalent Influenza Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Multivalent Influenza Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Multivalent Influenza Vaccines Market Size Forecast by Region
10.2.4 South America Multivalent Influenza Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Multivalent Influenza Vaccines by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Multivalent Influenza Vaccines Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Multivalent Influenza Vaccines by Type (2025-2030)
11.1.2 Global Multivalent Influenza Vaccines Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Multivalent Influenza Vaccines by Type (2025-2030)
11.2 Global Multivalent Influenza Vaccines Market Forecast by Application (2025-2030)
11.2.1 Global Multivalent Influenza Vaccines Sales (Kilotons) Forecast by Application
11.2.2 Global Multivalent Influenza Vaccines Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Multivalent Influenza Vaccines
1.2 Key Market Segments
1.2.1 Multivalent Influenza Vaccines Segment by Type
1.2.2 Multivalent Influenza Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MULTIVALENT INFLUENZA VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Multivalent Influenza Vaccines Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Multivalent Influenza Vaccines Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MULTIVALENT INFLUENZA VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Global Multivalent Influenza Vaccines Sales by Manufacturers (2019-2024)
3.2 Global Multivalent Influenza Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.3 Multivalent Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Multivalent Influenza Vaccines Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Multivalent Influenza Vaccines Sales Sites, Area Served, Product Type
3.6 Multivalent Influenza Vaccines Market Competitive Situation and Trends
3.6.1 Multivalent Influenza Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Multivalent Influenza Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MULTIVALENT INFLUENZA VACCINES INDUSTRY CHAIN ANALYSIS
4.1 Multivalent Influenza Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MULTIVALENT INFLUENZA VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MULTIVALENT INFLUENZA VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Multivalent Influenza Vaccines Sales Market Share by Type (2019-2024)
6.3 Global Multivalent Influenza Vaccines Market Size Market Share by Type (2019-2024)
6.4 Global Multivalent Influenza Vaccines Price by Type (2019-2024)
7 MULTIVALENT INFLUENZA VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Multivalent Influenza Vaccines Market Sales by Application (2019-2024)
7.3 Global Multivalent Influenza Vaccines Market Size (M USD) by Application (2019-2024)
7.4 Global Multivalent Influenza Vaccines Sales Growth Rate by Application (2019-2024)
8 MULTIVALENT INFLUENZA VACCINES MARKET SEGMENTATION BY REGION
8.1 Global Multivalent Influenza Vaccines Sales by Region
8.1.1 Global Multivalent Influenza Vaccines Sales by Region
8.1.2 Global Multivalent Influenza Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Multivalent Influenza Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Multivalent Influenza Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Multivalent Influenza Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Multivalent Influenza Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Multivalent Influenza Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Sanofi
9.1.1 Sanofi Multivalent Influenza Vaccines Basic Information
9.1.2 Sanofi Multivalent Influenza Vaccines Product Overview
9.1.3 Sanofi Multivalent Influenza Vaccines Product Market Performance
9.1.4 Sanofi Business Overview
9.1.5 Sanofi Multivalent Influenza Vaccines SWOT Analysis
9.1.6 Sanofi Recent Developments
9.2 CSL
9.2.1 CSL Multivalent Influenza Vaccines Basic Information
9.2.2 CSL Multivalent Influenza Vaccines Product Overview
9.2.3 CSL Multivalent Influenza Vaccines Product Market Performance
9.2.4 CSL Business Overview
9.2.5 CSL Multivalent Influenza Vaccines SWOT Analysis
9.2.6 CSL Recent Developments
9.3 GSK
9.3.1 GSK Multivalent Influenza Vaccines Basic Information
9.3.2 GSK Multivalent Influenza Vaccines Product Overview
9.3.3 GSK Multivalent Influenza Vaccines Product Market Performance
9.3.4 GSK Multivalent Influenza Vaccines SWOT Analysis
9.3.5 GSK Business Overview
9.3.6 GSK Recent Developments
9.4 Viatris
9.4.1 Viatris Multivalent Influenza Vaccines Basic Information
9.4.2 Viatris Multivalent Influenza Vaccines Product Overview
9.4.3 Viatris Multivalent Influenza Vaccines Product Market Performance
9.4.4 Viatris Business Overview
9.4.5 Viatris Recent Developments
9.5 AstraZeneca
9.5.1 AstraZeneca Multivalent Influenza Vaccines Basic Information
9.5.2 AstraZeneca Multivalent Influenza Vaccines Product Overview
9.5.3 AstraZeneca Multivalent Influenza Vaccines Product Market Performance
9.5.4 AstraZeneca Business Overview
9.5.5 AstraZeneca Recent Developments
9.6 Hualan Bio
9.6.1 Hualan Bio Multivalent Influenza Vaccines Basic Information
9.6.2 Hualan Bio Multivalent Influenza Vaccines Product Overview
9.6.3 Hualan Bio Multivalent Influenza Vaccines Product Market Performance
9.6.4 Hualan Bio Business Overview
9.6.5 Hualan Bio Recent Developments
9.7 Changchun Institute of Biological
9.7.1 Changchun Institute of Biological Multivalent Influenza Vaccines Basic Information
9.7.2 Changchun Institute of Biological Multivalent Influenza Vaccines Product Overview
9.7.3 Changchun Institute of Biological Multivalent Influenza Vaccines Product Market Performance
9.7.4 Changchun Institute of Biological Business Overview
9.7.5 Changchun Institute of Biological Recent Developments
9.8 Sinovac
9.8.1 Sinovac Multivalent Influenza Vaccines Basic Information
9.8.2 Sinovac Multivalent Influenza Vaccines Product Overview
9.8.3 Sinovac Multivalent Influenza Vaccines Product Market Performance
9.8.4 Sinovac Business Overview
9.8.5 Sinovac Recent Developments
9.9 Bcht Biotechnology
9.9.1 Bcht Biotechnology Multivalent Influenza Vaccines Basic Information
9.9.2 Bcht Biotechnology Multivalent Influenza Vaccines Product Overview
9.9.3 Bcht Biotechnology Multivalent Influenza Vaccines Product Market Performance
9.9.4 Bcht Biotechnology Business Overview
9.9.5 Bcht Biotechnology Recent Developments
9.10 Jiangsu GDK
9.10.1 Jiangsu GDK Multivalent Influenza Vaccines Basic Information
9.10.2 Jiangsu GDK Multivalent Influenza Vaccines Product Overview
9.10.3 Jiangsu GDK Multivalent Influenza Vaccines Product Market Performance
9.10.4 Jiangsu GDK Business Overview
9.10.5 Jiangsu GDK Recent Developments
9.11 KM Biologics
9.11.1 KM Biologics Multivalent Influenza Vaccines Basic Information
9.11.2 KM Biologics Multivalent Influenza Vaccines Product Overview
9.11.3 KM Biologics Multivalent Influenza Vaccines Product Market Performance
9.11.4 KM Biologics Business Overview
9.11.5 KM Biologics Recent Developments
9.12 ADIMMUNE Corporation
9.12.1 ADIMMUNE Corporation Multivalent Influenza Vaccines Basic Information
9.12.2 ADIMMUNE Corporation Multivalent Influenza Vaccines Product Overview
9.12.3 ADIMMUNE Corporation Multivalent Influenza Vaccines Product Market Performance
9.12.4 ADIMMUNE Corporation Business Overview
9.12.5 ADIMMUNE Corporation Recent Developments
9.13 Aleph Biomedical
9.13.1 Aleph Biomedical Multivalent Influenza Vaccines Basic Information
9.13.2 Aleph Biomedical Multivalent Influenza Vaccines Product Overview
9.13.3 Aleph Biomedical Multivalent Influenza Vaccines Product Market Performance
9.13.4 Aleph Biomedical Business Overview
9.13.5 Aleph Biomedical Recent Developments
9.14 Shanghai Institute of Biological Products
9.14.1 Shanghai Institute of Biological Products Multivalent Influenza Vaccines Basic Information
9.14.2 Shanghai Institute of Biological Products Multivalent Influenza Vaccines Product Overview
9.14.3 Shanghai Institute of Biological Products Multivalent Influenza Vaccines Product Market Performance
9.14.4 Shanghai Institute of Biological Products Business Overview
9.14.5 Shanghai Institute of Biological Products Recent Developments
9.15 Zhongyianke Biotech
9.15.1 Zhongyianke Biotech Multivalent Influenza Vaccines Basic Information
9.15.2 Zhongyianke Biotech Multivalent Influenza Vaccines Product Overview
9.15.3 Zhongyianke Biotech Multivalent Influenza Vaccines Product Market Performance
9.15.4 Zhongyianke Biotech Business Overview
9.15.5 Zhongyianke Biotech Recent Developments
9.16 Wuhan Institute of Biological Products
9.16.1 Wuhan Institute of Biological Products Multivalent Influenza Vaccines Basic Information
9.16.2 Wuhan Institute of Biological Products Multivalent Influenza Vaccines Product Overview
9.16.3 Wuhan Institute of Biological Products Multivalent Influenza Vaccines Product Market Performance
9.16.4 Wuhan Institute of Biological Products Business Overview
9.16.5 Wuhan Institute of Biological Products Recent Developments
10 MULTIVALENT INFLUENZA VACCINES MARKET FORECAST BY REGION
10.1 Global Multivalent Influenza Vaccines Market Size Forecast
10.2 Global Multivalent Influenza Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Multivalent Influenza Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Multivalent Influenza Vaccines Market Size Forecast by Region
10.2.4 South America Multivalent Influenza Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Multivalent Influenza Vaccines by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Multivalent Influenza Vaccines Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Multivalent Influenza Vaccines by Type (2025-2030)
11.1.2 Global Multivalent Influenza Vaccines Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Multivalent Influenza Vaccines by Type (2025-2030)
11.2 Global Multivalent Influenza Vaccines Market Forecast by Application (2025-2030)
11.2.1 Global Multivalent Influenza Vaccines Sales (Kilotons) Forecast by Application
11.2.2 Global Multivalent Influenza Vaccines Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Multivalent Influenza Vaccines Market Size Comparison by Region (M USD)
Table 5. Global Multivalent Influenza Vaccines Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Multivalent Influenza Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Multivalent Influenza Vaccines Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Multivalent Influenza Vaccines Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multivalent Influenza Vaccines as of 2022)
Table 10. Global Market Multivalent Influenza Vaccines Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Multivalent Influenza Vaccines Sales Sites and Area Served
Table 12. Manufacturers Multivalent Influenza Vaccines Product Type
Table 13. Global Multivalent Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Multivalent Influenza Vaccines
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Multivalent Influenza Vaccines Market Challenges
Table 22. Global Multivalent Influenza Vaccines Sales by Type (Kilotons)
Table 23. Global Multivalent Influenza Vaccines Market Size by Type (M USD)
Table 24. Global Multivalent Influenza Vaccines Sales (Kilotons) by Type (2019-2024)
Table 25. Global Multivalent Influenza Vaccines Sales Market Share by Type (2019-2024)
Table 26. Global Multivalent Influenza Vaccines Market Size (M USD) by Type (2019-2024)
Table 27. Global Multivalent Influenza Vaccines Market Size Share by Type (2019-2024)
Table 28. Global Multivalent Influenza Vaccines Price (USD/Ton) by Type (2019-2024)
Table 29. Global Multivalent Influenza Vaccines Sales (Kilotons) by Application
Table 30. Global Multivalent Influenza Vaccines Market Size by Application
Table 31. Global Multivalent Influenza Vaccines Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Multivalent Influenza Vaccines Sales Market Share by Application (2019-2024)
Table 33. Global Multivalent Influenza Vaccines Sales by Application (2019-2024) & (M USD)
Table 34. Global Multivalent Influenza Vaccines Market Share by Application (2019-2024)
Table 35. Global Multivalent Influenza Vaccines Sales Growth Rate by Application (2019-2024)
Table 36. Global Multivalent Influenza Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Multivalent Influenza Vaccines Sales Market Share by Region (2019-2024)
Table 38. North America Multivalent Influenza Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Multivalent Influenza Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Multivalent Influenza Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Multivalent Influenza Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Multivalent Influenza Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 43. Sanofi Multivalent Influenza Vaccines Basic Information
Table 44. Sanofi Multivalent Influenza Vaccines Product Overview
Table 45. Sanofi Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Sanofi Business Overview
Table 47. Sanofi Multivalent Influenza Vaccines SWOT Analysis
Table 48. Sanofi Recent Developments
Table 49. CSL Multivalent Influenza Vaccines Basic Information
Table 50. CSL Multivalent Influenza Vaccines Product Overview
Table 51. CSL Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. CSL Business Overview
Table 53. CSL Multivalent Influenza Vaccines SWOT Analysis
Table 54. CSL Recent Developments
Table 55. GSK Multivalent Influenza Vaccines Basic Information
Table 56. GSK Multivalent Influenza Vaccines Product Overview
Table 57. GSK Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. GSK Multivalent Influenza Vaccines SWOT Analysis
Table 59. GSK Business Overview
Table 60. GSK Recent Developments
Table 61. Viatris Multivalent Influenza Vaccines Basic Information
Table 62. Viatris Multivalent Influenza Vaccines Product Overview
Table 63. Viatris Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Viatris Business Overview
Table 65. Viatris Recent Developments
Table 66. AstraZeneca Multivalent Influenza Vaccines Basic Information
Table 67. AstraZeneca Multivalent Influenza Vaccines Product Overview
Table 68. AstraZeneca Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Recent Developments
Table 71. Hualan Bio Multivalent Influenza Vaccines Basic Information
Table 72. Hualan Bio Multivalent Influenza Vaccines Product Overview
Table 73. Hualan Bio Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Hualan Bio Business Overview
Table 75. Hualan Bio Recent Developments
Table 76. Changchun Institute of Biological Multivalent Influenza Vaccines Basic Information
Table 77. Changchun Institute of Biological Multivalent Influenza Vaccines Product Overview
Table 78. Changchun Institute of Biological Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Changchun Institute of Biological Business Overview
Table 80. Changchun Institute of Biological Recent Developments
Table 81. Sinovac Multivalent Influenza Vaccines Basic Information
Table 82. Sinovac Multivalent Influenza Vaccines Product Overview
Table 83. Sinovac Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Sinovac Business Overview
Table 85. Sinovac Recent Developments
Table 86. Bcht Biotechnology Multivalent Influenza Vaccines Basic Information
Table 87. Bcht Biotechnology Multivalent Influenza Vaccines Product Overview
Table 88. Bcht Biotechnology Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Bcht Biotechnology Business Overview
Table 90. Bcht Biotechnology Recent Developments
Table 91. Jiangsu GDK Multivalent Influenza Vaccines Basic Information
Table 92. Jiangsu GDK Multivalent Influenza Vaccines Product Overview
Table 93. Jiangsu GDK Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Jiangsu GDK Business Overview
Table 95. Jiangsu GDK Recent Developments
Table 96. KM Biologics Multivalent Influenza Vaccines Basic Information
Table 97. KM Biologics Multivalent Influenza Vaccines Product Overview
Table 98. KM Biologics Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. KM Biologics Business Overview
Table 100. KM Biologics Recent Developments
Table 101. ADIMMUNE Corporation Multivalent Influenza Vaccines Basic Information
Table 102. ADIMMUNE Corporation Multivalent Influenza Vaccines Product Overview
Table 103. ADIMMUNE Corporation Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. ADIMMUNE Corporation Business Overview
Table 105. ADIMMUNE Corporation Recent Developments
Table 106. Aleph Biomedical Multivalent Influenza Vaccines Basic Information
Table 107. Aleph Biomedical Multivalent Influenza Vaccines Product Overview
Table 108. Aleph Biomedical Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Aleph Biomedical Business Overview
Table 110. Aleph Biomedical Recent Developments
Table 111. Shanghai Institute of Biological Products Multivalent Influenza Vaccines Basic Information
Table 112. Shanghai Institute of Biological Products Multivalent Influenza Vaccines Product Overview
Table 113. Shanghai Institute of Biological Products Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Shanghai Institute of Biological Products Business Overview
Table 115. Shanghai Institute of Biological Products Recent Developments
Table 116. Zhongyianke Biotech Multivalent Influenza Vaccines Basic Information
Table 117. Zhongyianke Biotech Multivalent Influenza Vaccines Product Overview
Table 118. Zhongyianke Biotech Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Zhongyianke Biotech Business Overview
Table 120. Zhongyianke Biotech Recent Developments
Table 121. Wuhan Institute of Biological Products Multivalent Influenza Vaccines Basic Information
Table 122. Wuhan Institute of Biological Products Multivalent Influenza Vaccines Product Overview
Table 123. Wuhan Institute of Biological Products Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Wuhan Institute of Biological Products Business Overview
Table 125. Wuhan Institute of Biological Products Recent Developments
Table 126. Global Multivalent Influenza Vaccines Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global Multivalent Influenza Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Multivalent Influenza Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America Multivalent Influenza Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Multivalent Influenza Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe Multivalent Influenza Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Multivalent Influenza Vaccines Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific Multivalent Influenza Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Multivalent Influenza Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America Multivalent Influenza Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Multivalent Influenza Vaccines Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Multivalent Influenza Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Multivalent Influenza Vaccines Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global Multivalent Influenza Vaccines Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Multivalent Influenza Vaccines Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global Multivalent Influenza Vaccines Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global Multivalent Influenza Vaccines Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Multivalent Influenza Vaccines Market Size Comparison by Region (M USD)
Table 5. Global Multivalent Influenza Vaccines Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Multivalent Influenza Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Multivalent Influenza Vaccines Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Multivalent Influenza Vaccines Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multivalent Influenza Vaccines as of 2022)
Table 10. Global Market Multivalent Influenza Vaccines Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Multivalent Influenza Vaccines Sales Sites and Area Served
Table 12. Manufacturers Multivalent Influenza Vaccines Product Type
Table 13. Global Multivalent Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Multivalent Influenza Vaccines
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Multivalent Influenza Vaccines Market Challenges
Table 22. Global Multivalent Influenza Vaccines Sales by Type (Kilotons)
Table 23. Global Multivalent Influenza Vaccines Market Size by Type (M USD)
Table 24. Global Multivalent Influenza Vaccines Sales (Kilotons) by Type (2019-2024)
Table 25. Global Multivalent Influenza Vaccines Sales Market Share by Type (2019-2024)
Table 26. Global Multivalent Influenza Vaccines Market Size (M USD) by Type (2019-2024)
Table 27. Global Multivalent Influenza Vaccines Market Size Share by Type (2019-2024)
Table 28. Global Multivalent Influenza Vaccines Price (USD/Ton) by Type (2019-2024)
Table 29. Global Multivalent Influenza Vaccines Sales (Kilotons) by Application
Table 30. Global Multivalent Influenza Vaccines Market Size by Application
Table 31. Global Multivalent Influenza Vaccines Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Multivalent Influenza Vaccines Sales Market Share by Application (2019-2024)
Table 33. Global Multivalent Influenza Vaccines Sales by Application (2019-2024) & (M USD)
Table 34. Global Multivalent Influenza Vaccines Market Share by Application (2019-2024)
Table 35. Global Multivalent Influenza Vaccines Sales Growth Rate by Application (2019-2024)
Table 36. Global Multivalent Influenza Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Multivalent Influenza Vaccines Sales Market Share by Region (2019-2024)
Table 38. North America Multivalent Influenza Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Multivalent Influenza Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Multivalent Influenza Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Multivalent Influenza Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Multivalent Influenza Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 43. Sanofi Multivalent Influenza Vaccines Basic Information
Table 44. Sanofi Multivalent Influenza Vaccines Product Overview
Table 45. Sanofi Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Sanofi Business Overview
Table 47. Sanofi Multivalent Influenza Vaccines SWOT Analysis
Table 48. Sanofi Recent Developments
Table 49. CSL Multivalent Influenza Vaccines Basic Information
Table 50. CSL Multivalent Influenza Vaccines Product Overview
Table 51. CSL Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. CSL Business Overview
Table 53. CSL Multivalent Influenza Vaccines SWOT Analysis
Table 54. CSL Recent Developments
Table 55. GSK Multivalent Influenza Vaccines Basic Information
Table 56. GSK Multivalent Influenza Vaccines Product Overview
Table 57. GSK Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. GSK Multivalent Influenza Vaccines SWOT Analysis
Table 59. GSK Business Overview
Table 60. GSK Recent Developments
Table 61. Viatris Multivalent Influenza Vaccines Basic Information
Table 62. Viatris Multivalent Influenza Vaccines Product Overview
Table 63. Viatris Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Viatris Business Overview
Table 65. Viatris Recent Developments
Table 66. AstraZeneca Multivalent Influenza Vaccines Basic Information
Table 67. AstraZeneca Multivalent Influenza Vaccines Product Overview
Table 68. AstraZeneca Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Recent Developments
Table 71. Hualan Bio Multivalent Influenza Vaccines Basic Information
Table 72. Hualan Bio Multivalent Influenza Vaccines Product Overview
Table 73. Hualan Bio Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Hualan Bio Business Overview
Table 75. Hualan Bio Recent Developments
Table 76. Changchun Institute of Biological Multivalent Influenza Vaccines Basic Information
Table 77. Changchun Institute of Biological Multivalent Influenza Vaccines Product Overview
Table 78. Changchun Institute of Biological Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Changchun Institute of Biological Business Overview
Table 80. Changchun Institute of Biological Recent Developments
Table 81. Sinovac Multivalent Influenza Vaccines Basic Information
Table 82. Sinovac Multivalent Influenza Vaccines Product Overview
Table 83. Sinovac Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Sinovac Business Overview
Table 85. Sinovac Recent Developments
Table 86. Bcht Biotechnology Multivalent Influenza Vaccines Basic Information
Table 87. Bcht Biotechnology Multivalent Influenza Vaccines Product Overview
Table 88. Bcht Biotechnology Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Bcht Biotechnology Business Overview
Table 90. Bcht Biotechnology Recent Developments
Table 91. Jiangsu GDK Multivalent Influenza Vaccines Basic Information
Table 92. Jiangsu GDK Multivalent Influenza Vaccines Product Overview
Table 93. Jiangsu GDK Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Jiangsu GDK Business Overview
Table 95. Jiangsu GDK Recent Developments
Table 96. KM Biologics Multivalent Influenza Vaccines Basic Information
Table 97. KM Biologics Multivalent Influenza Vaccines Product Overview
Table 98. KM Biologics Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. KM Biologics Business Overview
Table 100. KM Biologics Recent Developments
Table 101. ADIMMUNE Corporation Multivalent Influenza Vaccines Basic Information
Table 102. ADIMMUNE Corporation Multivalent Influenza Vaccines Product Overview
Table 103. ADIMMUNE Corporation Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. ADIMMUNE Corporation Business Overview
Table 105. ADIMMUNE Corporation Recent Developments
Table 106. Aleph Biomedical Multivalent Influenza Vaccines Basic Information
Table 107. Aleph Biomedical Multivalent Influenza Vaccines Product Overview
Table 108. Aleph Biomedical Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Aleph Biomedical Business Overview
Table 110. Aleph Biomedical Recent Developments
Table 111. Shanghai Institute of Biological Products Multivalent Influenza Vaccines Basic Information
Table 112. Shanghai Institute of Biological Products Multivalent Influenza Vaccines Product Overview
Table 113. Shanghai Institute of Biological Products Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Shanghai Institute of Biological Products Business Overview
Table 115. Shanghai Institute of Biological Products Recent Developments
Table 116. Zhongyianke Biotech Multivalent Influenza Vaccines Basic Information
Table 117. Zhongyianke Biotech Multivalent Influenza Vaccines Product Overview
Table 118. Zhongyianke Biotech Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Zhongyianke Biotech Business Overview
Table 120. Zhongyianke Biotech Recent Developments
Table 121. Wuhan Institute of Biological Products Multivalent Influenza Vaccines Basic Information
Table 122. Wuhan Institute of Biological Products Multivalent Influenza Vaccines Product Overview
Table 123. Wuhan Institute of Biological Products Multivalent Influenza Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Wuhan Institute of Biological Products Business Overview
Table 125. Wuhan Institute of Biological Products Recent Developments
Table 126. Global Multivalent Influenza Vaccines Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global Multivalent Influenza Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Multivalent Influenza Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America Multivalent Influenza Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Multivalent Influenza Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe Multivalent Influenza Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Multivalent Influenza Vaccines Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific Multivalent Influenza Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Multivalent Influenza Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America Multivalent Influenza Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Multivalent Influenza Vaccines Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Multivalent Influenza Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Multivalent Influenza Vaccines Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global Multivalent Influenza Vaccines Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Multivalent Influenza Vaccines Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global Multivalent Influenza Vaccines Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global Multivalent Influenza Vaccines Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Multivalent Influenza Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Multivalent Influenza Vaccines Market Size (M USD), 2019-2030
Figure 5. Global Multivalent Influenza Vaccines Market Size (M USD) (2019-2030)
Figure 6. Global Multivalent Influenza Vaccines Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Multivalent Influenza Vaccines Market Size by Country (M USD)
Figure 11. Multivalent Influenza Vaccines Sales Share by Manufacturers in 2023
Figure 12. Global Multivalent Influenza Vaccines Revenue Share by Manufacturers in 2023
Figure 13. Multivalent Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Multivalent Influenza Vaccines Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Multivalent Influenza Vaccines Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Multivalent Influenza Vaccines Market Share by Type
Figure 18. Sales Market Share of Multivalent Influenza Vaccines by Type (2019-2024)
Figure 19. Sales Market Share of Multivalent Influenza Vaccines by Type in 2023
Figure 20. Market Size Share of Multivalent Influenza Vaccines by Type (2019-2024)
Figure 21. Market Size Market Share of Multivalent Influenza Vaccines by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Multivalent Influenza Vaccines Market Share by Application
Figure 24. Global Multivalent Influenza Vaccines Sales Market Share by Application (2019-2024)
Figure 25. Global Multivalent Influenza Vaccines Sales Market Share by Application in 2023
Figure 26. Global Multivalent Influenza Vaccines Market Share by Application (2019-2024)
Figure 27. Global Multivalent Influenza Vaccines Market Share by Application in 2023
Figure 28. Global Multivalent Influenza Vaccines Sales Growth Rate by Application (2019-2024)
Figure 29. Global Multivalent Influenza Vaccines Sales Market Share by Region (2019-2024)
Figure 30. North America Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Multivalent Influenza Vaccines Sales Market Share by Country in 2023
Figure 32. U.S. Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Multivalent Influenza Vaccines Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Multivalent Influenza Vaccines Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Multivalent Influenza Vaccines Sales Market Share by Country in 2023
Figure 37. Germany Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Multivalent Influenza Vaccines Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Multivalent Influenza Vaccines Sales Market Share by Region in 2023
Figure 44. China Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Multivalent Influenza Vaccines Sales and Growth Rate (Kilotons)
Figure 50. South America Multivalent Influenza Vaccines Sales Market Share by Country in 2023
Figure 51. Brazil Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Multivalent Influenza Vaccines Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Multivalent Influenza Vaccines Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Multivalent Influenza Vaccines Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Multivalent Influenza Vaccines Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Multivalent Influenza Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Multivalent Influenza Vaccines Market Share Forecast by Type (2025-2030)
Figure 65. Global Multivalent Influenza Vaccines Sales Forecast by Application (2025-2030)
Figure 66. Global Multivalent Influenza Vaccines Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Multivalent Influenza Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Multivalent Influenza Vaccines Market Size (M USD), 2019-2030
Figure 5. Global Multivalent Influenza Vaccines Market Size (M USD) (2019-2030)
Figure 6. Global Multivalent Influenza Vaccines Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Multivalent Influenza Vaccines Market Size by Country (M USD)
Figure 11. Multivalent Influenza Vaccines Sales Share by Manufacturers in 2023
Figure 12. Global Multivalent Influenza Vaccines Revenue Share by Manufacturers in 2023
Figure 13. Multivalent Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Multivalent Influenza Vaccines Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Multivalent Influenza Vaccines Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Multivalent Influenza Vaccines Market Share by Type
Figure 18. Sales Market Share of Multivalent Influenza Vaccines by Type (2019-2024)
Figure 19. Sales Market Share of Multivalent Influenza Vaccines by Type in 2023
Figure 20. Market Size Share of Multivalent Influenza Vaccines by Type (2019-2024)
Figure 21. Market Size Market Share of Multivalent Influenza Vaccines by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Multivalent Influenza Vaccines Market Share by Application
Figure 24. Global Multivalent Influenza Vaccines Sales Market Share by Application (2019-2024)
Figure 25. Global Multivalent Influenza Vaccines Sales Market Share by Application in 2023
Figure 26. Global Multivalent Influenza Vaccines Market Share by Application (2019-2024)
Figure 27. Global Multivalent Influenza Vaccines Market Share by Application in 2023
Figure 28. Global Multivalent Influenza Vaccines Sales Growth Rate by Application (2019-2024)
Figure 29. Global Multivalent Influenza Vaccines Sales Market Share by Region (2019-2024)
Figure 30. North America Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Multivalent Influenza Vaccines Sales Market Share by Country in 2023
Figure 32. U.S. Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Multivalent Influenza Vaccines Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Multivalent Influenza Vaccines Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Multivalent Influenza Vaccines Sales Market Share by Country in 2023
Figure 37. Germany Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Multivalent Influenza Vaccines Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Multivalent Influenza Vaccines Sales Market Share by Region in 2023
Figure 44. China Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Multivalent Influenza Vaccines Sales and Growth Rate (Kilotons)
Figure 50. South America Multivalent Influenza Vaccines Sales Market Share by Country in 2023
Figure 51. Brazil Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Multivalent Influenza Vaccines Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Multivalent Influenza Vaccines Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Multivalent Influenza Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Multivalent Influenza Vaccines Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Multivalent Influenza Vaccines Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Multivalent Influenza Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Multivalent Influenza Vaccines Market Share Forecast by Type (2025-2030)
Figure 65. Global Multivalent Influenza Vaccines Sales Forecast by Application (2025-2030)
Figure 66. Global Multivalent Influenza Vaccines Market Share Forecast by Application (2025-2030)
